EHA 2020 | Overcoming lack of diversity in cancer clinical trials
Ruben Mesa
Ruben Mesa, MD, of UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, highlights the importance of overcoming the lack of diversity in patients enrolled in clinical trials. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Related videos
1:53 European regulation and access to advanced therapies
Aurélie Mahalatchimy
5:40 Gene editing: legal and ethical considerations
Aurélie Mahalatchimy
3:02 NK-CAR immunotherapy development over the past 12 months
Evelyn Ullrich
1:17 NK-CAR immunotherapy: the next steps
Evelyn Ullrich
3:06 Safety and outcome of prophylactic high-dose donor CD45RO+ memory T-cells after allo-HSCT
Mercedes Gasior Kabat
